ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,817 | 2,791 | -6,199 | -5,453 | -3,229 |
| Depreciation Amortization | 33 | 118 | 85 | 55 | 28 |
| Accounts receivable | 6,996 | -10,511 | -18 | N/A | N/A |
| Other Working Capital | 5,119 | -8,983 | -1,088 | -406 | 52 |
| Other Operating Activity | -6,775 | 11,587 | 1,042 | 975 | 859 |
| Operating Cash Flow | $3,555 | $-4,997 | $-6,177 | $-4,830 | $-2,290 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -61 | 4,995 | -1,113 | 4,419 | 1,806 |
| PPE Investments | N/A | -39 | -39 | -4 | -1 |
| Investing Cash Flow | $-61 | $4,956 | $-1,152 | $4,415 | $1,806 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 143 | 7,384 | 7,384 | 237 | 244 |
| Financing Cash Flow | $143 | $7,384 | $7,384 | $237 | $244 |
| Beginning Cash Position | 7,654 | 311 | 311 | 311 | 311 |
| End Cash Position | 11,291 | 7,654 | 366 | 134 | 70 |
| Net Cash Flow | $3,637 | $7,343 | $56 | $-177 | $-241 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,555 | -4,997 | -6,177 | -4,830 | -2,290 |
| Capital Expenditure | N/A | -39 | -39 | -4 | -1 |
| Free Cash Flow | 3,555 | -5,036 | -6,216 | -4,834 | -2,290 |